Tranexamic acid-13C2,15N
Based on 1 Customer Validation
Tranexamic acid-13C2,15N (Cyclocapron-13C2,15N) is the 13C2 and 15N labeled Tranexamic acid. Tranexamic acid is an antifibrinolytic agent that alleviates liver damage and fibrosis in mouse models of chronic bile duct injury.
For research use only. We do not sell to patients.
- CAS No.: 1292837-95-6
- Formula: C613C2H1515NO2
- Molecular Weight:160.19
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 1292837-95-6
-
Unlabeled Cas 1197-18-8
-
Molecular Weight 160.19
-
Formula C613C2H1515NO2
-
SMILES
O[13C]([C@@H]1CC[C@H](CC1)[13CH2][15NH2])=O
-
Synonyms
Cyclocapron-13C2,15N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Boström J, et al. Potent fibrinolysis inhibitor discovered by shape and electrostatic complementarity to the drug tranexamic acid. J Med Chem. 2013 Apr 25;56(8):3273-80. [Content Brief]
[2]. Joshi N, et al. The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury. J Pharmacol Exp Ther. 2014 Jun;349(3):383-92. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Tranexamic acid-13C2,15N Related Classifications
HY-B0149S3 Related Classifications
Powered by Bioz